MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer

Cancer Chemotherapy and Pharmacology

Volumn 65, Issue 3, 2010, Pages 437-446

  Sun, Ning ^a   Sun, Xinchen ^a,b   Chen, Baoan ^a,b   Cheng, Hongyan ^b   Feng, Jifeng ^c   Cheng, Lu ^b   Lu, Zuhong ^b  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c JIANGSU CANCER HOSPITAL   (China)

Author keywords

Chemotherapy; Gene chip; GSTP1; MRP2; Non small cell lung cancer (NSCLC); Single nucleotide polymorphism

Indexed keywords

CARBOPLATIN; CISPLATIN; DNA; DOCETAXEL; GEMCITABINE; GLUTATHIONE TRANSFERASE P1; MULTIDRUG RESISTANCE PROTEIN 2; NAVELBINE; PACLITAXEL; ACTIN BINDING PROTEIN; ANTINEOPLASTIC AGENT; GSTP1 PROTEIN, HUMAN; KLHL1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DRUG DISPOSITION; DRUG EFFICACY; DRUG METABOLISM; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; CLINICAL TRIAL; GENE FREQUENCY; GENETICS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GENE FREQUENCY; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PACLITAXEL; POLYMORPHISM, SINGLE NUCLEOTIDE; TREATMENT OUTCOME;

EID: 75549090701     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-1046-1     Document Type: Article

References (51)

1. JJ Guilbert 2003 The world health report 2002: reducing risks, promoting healthy life Educ Health (Abingdon) 16 2 230 10.1080/1357628031000116808 1:STN:280:DC%2BD2c%2FkslCiuw%3D%3D (Pubitemid 36939565)
2. SG Spiro GA Silvestri 2005 The treatment of advanced non-small cell lung cancer Curr Opin Pulm Med 11 287 291 10.1097/01.mcp.0000166590.03042.56 1:CAS:528:DC%2BD2MXmvVamtL8%3D 15928493
3. O Breathnach B Freidlin B Conley, et al. 2001 Twenty-two years of phase III trials for patients with advanced non-small cell lung cancer: sobering results J Clin Oncol 19 1734 1742 1:STN:280:DC%2BD3M3gsl2ntw%3D%3D 11251004
4. Stephens RJ, Fairlamb D, Gower N, et al. (2002) The Big Lung Trial (BLT): determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC)-Preliminary results in the supportive care setting. Proc Am Soc Clin Oncol 21 (Abstract 1161)
5. CA Rabik ME Dolan 2007 Molecular mechanisms of resistance and toxicity associated with platinating agents Cancer Treat Rev 33 1 9 23 10.1016/j.ctrv.2006.09.006 1:CAS:528:DC%2BD2sXhtVartrw%3D 17084534 (Pubitemid 46137553)
6. K Viktorsson L De Petris R Lewensohn 2005 The role of p53 in treatment responses of lung cancer Biochem Biophys Res Commun 331 868 880 10.1016/j.bbrc.2005.03.192 1:CAS:528:DC%2BD2MXjslKjtb4%3D 15865943 (Pubitemid 40615518)
7. RC Strange MA Spiteri S Ramachandran AA Fryer 2001 Glutathione-S transferase family of enzymes Mutat Res 482 1-2 21 26 1:CAS:528: DC%2BD3MXmsFeltb8%3D 11535245
8. MA Fuertes J Castilla C Alonso, et al. 2003 Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways Curr Med Chem 10 257 266 1:CAS:528:DC%2BD3sXlt1Ggsg%3D%3D
9. B Mannervik PG Board JD Hayes I Listowsky WR Pearson 2005 Nomenclature for mammalian soluble glutathione transferases Methods Enzymol 401 1 8 10.1016/S0076-6879(05)01001-3 1:CAS:528:DC%2BD28XoslCjurs%3D 16399376 (Pubitemid 43052383)
10. P Terrier AJ Townsend JM Coindre TJ Triche KH Cowan 1990 An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue Am J Pathol 137 845 853 1:CAS:528:DyaK3MXnvFSgug%3D%3D 1977319
11. S Anttila A Hirvonen H Vainio K Husgafvel-Pursiainen JD Hayes B Ketterer 1993 Immunohistochemical localization of glutathione S-transferases in human lung cancer Cancer Res 53 5643 5648 1:CAS:528:DyaK2cXivVSitg%3D%3D 8242618
12. F D'Al'o MT Voso F Guidi, et al. 2004 Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukemia Haematologica 89 6 664 670
13. TR Rebbeck 1997 Molecular epidemiology of the human glutathione S transferase genotypes GSTM1 and GSTT1 in cancer susceptibility Cancer Epidemiol Biomarkers Prev 6 9 733 743 1:STN:280:DyaK2svktl2isw%3D%3D 9298582
14. A Haimeur G Conseil RG Deeley SP Cole 2004 The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation Curr Drug Metab 5 21 53 10.2174/1389200043489199 1:CAS:528:DC%2BD2cXhvVCisLo%3D 14965249 (Pubitemid 38294344)
15. JF Rebbeor GC Connolly N Ballatori 2002 Inhibition of Mrp2- and Ycf1p-mediated transport by reducing agents: evidence for GSH transport on rat MRP2 Biochim Biophys Acta 1559 171 178 10.1016/S0005-2736(01)00454-0 1:CAS:528:DC%2BD38XisVWrs78%3D 11853683 (Pubitemid 34164425)
16. EM Leslie A Haimeur MP Waalkes 2004 Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1): evidence that a tri-glutathione conjugate is required J Biol Chem 279 31 32700 32708 10.1074/jbc.M404912200 1:CAS:528:DC%2BD2cXmtVChtLg%3D 15161912 (Pubitemid 39014729)
17. M Takano R Yumoto T Murakami 2006 Expression and function of efflux drug transporters in the intestine Pharmacol Ther 109 137 161 10.1016/j.pharmthera. 2005.06.005 1:CAS:528:DC%2BD2MXht12ktbbP 16209890 (Pubitemid 41740818)
18. P Borst R Evers M Kool J Wijnholds 2000 A family of drug transporters: the multidrug resistance-associated proteins J Natl Cancer Inst 92 1295 1302 10.1093/jnci/92.16.1295 1:CAS:528:DC%2BD3cXmtlektr8%3D 10944550
19. K Taniguchi M Wada K Kohno, et al. 1996 A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin resistant human cancer cell lines with decreased drug accumulation Cancer Res 56 4124 4129 1:CAS:528:DyaK28XlslGgsbg%3D 8797578
20. E Bakos R Evers JA Sinkule A Varadi P Borst B Sarkadi 2000 Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions Mol Pharmacol 57 760 768 1:CAS:528:DC%2BD3cXit1ehurk%3D 10727523
21. T Bernig SJ Chanock 2006 Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer Expert Rev Mol Diagn 6 319 331 10.1586/14737159.6.3.319 1:CAS:528:DC%2BD28XmtlOhsrc%3D 16706736 (Pubitemid 44174338)
22. AB Miller B Hoogstraten M Staquet A Winkler 1981 Reporting results of cancer treatment Cancer 47 207 214 10.1002/1097-0142(19810101)47:1<207::AID- CNCR2820470134>3.0.CO;2-6 1:STN:280:DyaL3M7htFOltw%3D%3D 7459811 (Pubitemid 11167383)
23. PF Xiao L Cheng Y Wan, et al. 2006 An improved gel-based DNA microarray method for detecting single nucleotide mismatch Electrophoresis 27 3904 3915 10.1002/elps.200500918 1:CAS:528:DC%2BD28XhtFygu77N 16960844 (Pubitemid 44608410)
24. WE Evans MV Relling 1999 Pharmacogenomics: translating functional genomics into rational therapeutics Science 286 487 491 10.1126/science.286. 5439.487 1:CAS:528:DyaK1MXmvVOhtL0%3D 10521338
25. JH Schiller D Harrington CP Belani, et al. 2002 Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer New Engl J Med 346 92 98 10.1056/NEJMoa011954 1:CAS:528:DC%2BD38Xkt1OlsQ%3D%3D 11784875 (Pubitemid 34438899)
26. P Zatloukal L Petruzelka M Zemanova, et al. 2003 Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial Lung Cancer 41 321 331 10.1016/S0169-5002(03)00233-2 12928123 (Pubitemid 36970188)
27. GV Scagliotti F De Marinis M Rinaldi, et al. 2002 Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer J Clin Oncol 20 21 4285 4291 10.1200/JCO.2002.02.068 1:CAS:528: DC%2BD38Xpt1CjtLs%3D 12409326 (Pubitemid 35266288)
28. T Oguri Y Fujiwara O Katoh, et al. 2000 Glutathione S transferase-pi gene expression and platinum drug exposure in human lung cancer Cancer Lett 156 93 99 10.1016/S0304-3835(00)00447-X 1:CAS:528:DC%2BD3cXjslOru70%3D 10840164 (Pubitemid 30326772)
29. CM Rudin ZJ Yang LM Schumaker, et al. 2003 Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance Cancer Res 63 2 312 318 1:CAS:528:DC%2BD3sXnt1Kksg%3D%3D 12543781
30. S Goto T Iida S Cho M Oka S Kohno T Kondo 1999 Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells Free Radic Res 31 6 549 558 10.1080/10715769900301121 1:CAS:528:DyaK1MXnvFygsb4%3D 10630679
31. DH Harpole Jr MB Moore JE Herndon II T Aloia TA D'Amico T Sporn 2001 The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer Clin Cancer Res 7 3 562 569 11297249
32. A Beeghly D Katsaros H Chen, et al. 2006 Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival Gynecol Oncol 100 2 330 337 10.1016/j.ygyno.2005.08.035 1:CAS:528:DC%2BD28XjsFKqsw%3D%3D 16199080 (Pubitemid 43075265)
33. E Hinoshita T Uchiumi K Taguchi, et al. 2000 Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas Clin Cancer Res 6 2401 2407 1:CAS:528: DC%2BD3cXksVGhsLg%3D 10873092
34. PG Board GC Weber M Coggan 1989 Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13-14 Ann Hum Genet 53 205 213 10.1111/j.1469-1809.1989.tb01786.x 1:STN:280:DyaK3c%2FoslKntw%3D%3D 2596826
35. MA Watson RK Stewart GB Smith TE Massey DA Bell 1998 Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution Carcinogenesis 19 2 275 280 10.1093/carcin/19.2.275 1:CAS:528:DyaK1cXhs1ykurk%3D 9498276 (Pubitemid 28375421)
36. JM Allan Wild ChP S Rollinson, et al. 2001 Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy induced leukaemia Proc Natl Acad Sci USA 98 11592 11597 10.1073/pnas.191211198 1:CAS:528:DC%2BD3MXnt12js7o%3D 11553769 (Pubitemid 32928773)
37. S Garte L Gaspari AK Alexandrie, et al. 2001 Metabolic gene polymorphism frequencies in control populations Cancer Epidemiol Biomarkers Prev 10 12 1239 1248 1:CAS:528:DC%2BD38XnsFSjsg%3D%3D 11751440
38. J Stoehlmacher DJ Park W Zhang, et al. 2002 Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer J Natl Cancer Inst 94 936 942 1:CAS:528:DC%2BD38XltlKrsrY%3D 12072547
39. J Stoehlmacher DJ Park W Zhang, et al. 2004 A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer Br J Cancer 91 344 354 1:CAS:528:DC%2BD2cXls1eht7o%3D 15213713
40. H Suzuki Y Sugiyama 2002 Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition Adv Drug Deliv Rev 54 10 1311 1331 10.1016/S0169-409X(02)00075-3 1:CAS:528:DC%2BD38XotF2ju74%3D 12406647 (Pubitemid 35284255)
41. S Ito I Ieiri M Tanabe A Suzuki S Higuchi K Otsubo 2001 Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects Pharmacogenetics 11 175 184 10.1097/00008571-200103000-00008 1:CAS:528:DC%2BD3MXisFSmtLc%3D 11266082 (Pubitemid 32216128)
42. K Sai Y Saito M Itoda, et al. 2008 Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese population Drug Metab Pharmacokinet 23 2 139 147 10.2133/dmpk.23.139 1:CAS:528:DC%2BD1cXotVynu7s%3D 18445995
43. M Itoda Y Saito A Soyama, et al. 2002 Polymorphisms in the ABCC2 (cMOAT/MRP2) gene found in 72 established cell lines derived from Japanese individuals: an association between single nucleotide polymorphisms in the 59-untranslated region and exon 28 Drug Metab Dispos 30 363 364 10.1124/dmd.30.4.363 1:CAS:528:DC%2BD38Xis1Ols7g%3D 11901087 (Pubitemid 34263818)
44. HE Meyer zu Schwabedissen G Jedlitschky M Gratz, et al. 2005 Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation Drug Metab Dispos 33 896 904 10.1124/dmd.104.003335 1:CAS:528:DC%2BD2MXlslWqs78%3D 15821043 (Pubitemid 41002769)
45. S Haenisch U Zimmermann E Dazert, et al. 2007 Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex Pharmacogenomics J 7 56 65 10.1038/sj.tpj.6500403 1:CAS:528: DC%2BD2sXhvFWktLY%3D 16788565 (Pubitemid 46322080)
46. JY Han HS Lim YK Yoo, et al. 2007 Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer Cancer 110 138 147 10.1002/cncr.22760 17534875 (Pubitemid 46986426)
47. B Liedert V Materna D Schadendorf J Thomale H Lage 2003 Overexpression of cMOAT(MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin J Invest Dermatol 121 1 172 176 10.1046/j.1523-1747.2003.12313.x 1:CAS:528:DC%2BD3sXmtVegtrc%3D 12839578 (Pubitemid 36900469)
48. XS Yang S Masayuki K Hitoshi, et al. 2004 Single nucleotide polymorphisms in MRP2 gene and their significance on chemosensitivity of advanced ovarian cancer J Pract Obstet Gynecol 20 3 153 155
49. FN Rehman M Audeh ES Abrams PW Hammond M Kenney TC Boles 1999 Immobilization of acrylamide-modified oligonucleotides by co-polymerization Nucleic Acids Res 27 649 655 10.1093/nar/27.2.649 1:CAS:528:DyaK1MXhtVKmt7Y%3D 9862993 (Pubitemid 29210036)
50. Y Wang DD Zhang WL Zheng, et al. 2008 Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray Cancer 112 61325 61336
51. Y Wan Y Wang JF Luo, et al. 2007 Bisulfite modification of immobilized DNAs for methylation detection Biosens Bioelectron 22 2415 2421 10.1016/j.bios.2006.08.033 1:CAS:528:DC%2BD2sXjslGmsbs%3D 17008087 (Pubitemid 46484227)